LXRbeta ligand binding domain in comlpex with small molecule inhibitors

LXRbeta ligand binding domain in comlpex with small molecule inhibitors Descriptor: 2-[5-chloranyl-6-[4-[[1,1,3-tris(oxidanylidene)-5-phenyl-2-propan-2-yl-1,2-thiazol-4-yl]amino]piperidin-1-yl]pyridin-3-yl]ethanoic acid, Oxysterols receptor LXR-beta, SULFATE ION Authors: Sandmark, J, Jansson, A. Deposit date: 2019-06-28 Release date: 2019-11-27 Last modified: 2024-05-15 Method: X-RAY DIFFRACTION (1.9 Å) Cite: Structural analysis identifies an escape route from the adverse lipogenic effects of liver X receptor ligands. Commun Biol, 2, 2019